Join to View Full Profile
1 Childrens Pl# DivSaint Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-454-2523
Dr. Ahmadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saumel Ahmadi is a Child Neurology specialist based in Saint Louis, MO. He completed his residency in Child Neurology and Pediatrics at the Washington University/B-JH/SLCH Consortium and graduated from Saurashtra University. His research contributions include several publications that have been recognized and cited by other academics. Notably, his work covers a range of topics such as patient specific drug discovery, rare neurogenetic conditions including Wolfram syndrome, pediatric multiple sclerosis, and cystic fibrosis, among others. His publications have been cited numerous times, highlighting his active engagement in clinical and translational research.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Child Neurology, 2020 - 2023
C.U. Shah Medical CollegeClass of 2010- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics
Certifications & Licensure
IL State Medical License 2024 - 2026
MO State Medical License 2018 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- 7 citationsHigh-Throughput Functional Analysis of CFTR and Other Apically Localized Proteins in iPSC-Derived Human Intestinal Organoids.Sunny Xia, Zoltán Bozóky, Michelle Di Paola, Onofrio Laselva, Saumel Ahmadi
Cells. 2021-12-04 - 8 citationsDifferential Diagnosis of Pediatric Multiple Sclerosis.Maria M. Galardi, Cristina Gaudioso, Saumel Ahmadi, Emily Evans, Laura Gilbert
Children. 2019-06-03 - 31 citationsLipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508delStephanie Chin, Maurita Hung, Amy Won, Yu-Sheng Wu, Saumel Ahmadi
Molecular Pharmacology. 2018-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
